Clinical trial

Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes

NCT00497198

Study summary

ClinicalTrials.gov

Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention MCI-196 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo of MCI-196 Tablet Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE2

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

MCI-196DRUG

Placebo of MCI-196 TabletDRUG

Sponsors & collaborators

Tanabe Pharma Corporationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00497198 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.